Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody ...
Leadership
Thomas G. Wiggans
Executive Chairman
Jeetinder Singh Mahal M.B.A.
President, COO, CEO & Director
Judith Anne Shizuru M.D., Ph.D.Founder
Co-Founder, Member of Scientific Advisory Board & Director
